WeVote

Bill

Bill

HB 967

Relating to a study on the prevalence of the use of psychoactive or psychotropic medication by persons who have committed suicide.

89th Legislature (2025) Introduced by Steve Toth

Texas legislature directs study examining psychiatric medication prevalence in suicide cases to identify treatment patterns and potential policy interventions.

Referred to Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 967

Legislative bill overview

HB 967 directs the state to conduct a comprehensive study on the prevalence of psychoactive and psychotropic medication use among individuals who have died by suicide in Texas. The bill requires data collection and analysis to determine patterns and correlations between psychiatric medication use and suicide outcomes.

Why is this important

Understanding medication patterns in suicide cases could inform public health policy, prescribing practices, and mental health interventions. Such data could help identify whether certain medications, dosages, or populations require enhanced monitoring or alternative treatment approaches, potentially saving lives through evidence-based policy adjustments.

Potential points of contention

  • Causation vs. correlation concerns: The study risks implying psychiatric medications cause suicide when correlation is often present because people at higher suicide risk are more likely to be prescribed these medications in the first place
  • Pharmaceutical industry implications: Results could fuel anti-medication sentiment or reduce willingness to prescribe needed treatments, potentially harming individuals who benefit from pharmacotherapy
  • Study methodology and scope: Questions about data sources (medical records, coroner reports), sample representativeness, confounding variables (untreated mental illness, substance abuse), and whether conclusions will be appropriately nuanced

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.